India japan research collaboration

In Spain, 45 patients with COVID-19 have taken Aplidin as part of a Phase 2 clinical trial, and Pharma Mar has released data on the first 27 patients. The drug reduced the amount of time they spent in the hospital, with 81% of patients returning home within 15 days, as opposed to the typical rate of 47%, according to the company. More expansive Phase 3 trials of the drug in COVID-19 patients are being planned in Spain and the U.S., said Pascal Besman, the company’s chief operating officer. … [Read more...] about ‘New weapon’ to kill COVID? UCSF-led team finds drug that could be far more effective than remdesivir

Bob responded by referring back to a “personal situation” that he said he had discussed with Boies and his brother before. “The other thing of concern, is that while Harvey has responded to a hundred emails concerning many business topics, the one email that he has failed to respond to is the one that commits him to treatment,” Bob wrote, adding that “there must be consequences if he doesn’t commit, otherwise it is worthless.” In a statement, he says he knew nothing of allegations of “significant sexual misconduct” until the rest of the world found out in 2017. At the time, Bob said, “he had come to the conclusion that his brother had issues regarding fidelity to his marriage and that he may have been suffering from some form of sex addiction.” Two women who worked for the Weinstein Company subsequently told the Times they escorted him to sex-addiction therapy in 2015. … [Read more...] about The Bad, Good Lawyer

Part of the challenge relates to how these vaccines are made. The first two authorized products use lipid nanoparticles to deliver a snippet of the coronavirus’ genetic material—called messenger RNA, or mRNA—into cells. The viral genes teach our cells how to make proteins that stimulate an immune response to the novel coronavirus. … [Read more...] about Here’s Why It Will Be Hard to Ramp Up COVID Vaxx Production